17.31
1.41%
0.24
Vorhandelsmarkt:
16.56
-0.75
-4.33%
Schlusskurs vom Vortag:
$17.07
Offen:
$17.13
24-Stunden-Volumen:
219.30K
Relative Volume:
0.75
Marktkapitalisierung:
$812.71M
Einnahmen:
$502.79M
Nettoeinkommen (Verlust:
$23.71M
KGV:
34.62
EPS:
0.5
Netto-Cashflow:
$6.35M
1W Leistung:
+2.30%
1M Leistung:
-14.94%
6M Leistung:
-14.69%
1J Leistung:
-1.98%
Core Laboratories Inc Stock (CLB) Company Profile
Firmenname
Core Laboratories Inc
Sektor
Telefon
713-328-2673
Adresse
6316 WINDFERN ROAD, HOUSTON
Vergleichen Sie CLB mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
CLB
Core Laboratories Inc
|
17.31 | 812.71M | 502.79M | 23.71M | 6.35M | 0.50 |
SLB
Schlumberger Ltd
|
38.34 | 54.14B | 36.00B | 4.48B | 5.15B | 3.11 |
BKR
Baker Hughes Company
|
41.02 | 40.59B | 27.30B | 2.24B | 1.79B | 2.23 |
HAL
Halliburton Co
|
27.19 | 23.89B | 23.07B | 2.55B | 2.40B | 2.87 |
TS
Tenaris S A Adr
|
37.79 | 20.58B | 13.09B | 2.65B | 2.52B | 4.5936 |
FTI
Technipfmc Plc
|
28.94 | 12.31B | 8.79B | 671.20M | 856.30M | 1.52 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-06-30 | Herabstufung | Citigroup | Neutral → Sell |
2023-04-18 | Herabstufung | BofA Securities | Neutral → Underperform |
2023-01-09 | Hochstufung | BofA Securities | Underperform → Neutral |
2022-10-07 | Hochstufung | Citigroup | Sell → Neutral |
2022-09-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
2022-04-18 | Herabstufung | Piper Sandler | Neutral → Underweight |
2021-10-18 | Herabstufung | BofA Securities | Neutral → Underperform |
2021-07-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2021-06-14 | Herabstufung | Citigroup | Neutral → Sell |
2020-12-18 | Herabstufung | JP Morgan | Neutral → Underweight |
2020-11-11 | Bestätigt | Cowen | Market Perform |
2020-10-13 | Hochstufung | BofA Securities | Underperform → Neutral |
2020-09-29 | Hochstufung | ABN Amro | Sell → Hold |
2020-07-16 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
2020-04-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
2020-03-09 | Herabstufung | BofA/Merrill | Buy → Underperform |
2020-03-09 | Herabstufung | Evercore ISI | Outperform → In-line |
2020-01-31 | Bestätigt | Cowen | Market Perform |
2020-01-30 | Fortgesetzt | Johnson Rice | Buy |
2020-01-14 | Eingeleitet | Bernstein | Mkt Perform |
2020-01-02 | Herabstufung | Stifel | Buy → Hold |
2019-12-31 | Bestätigt | Cowen | Market Perform |
2019-07-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
2019-02-25 | Hochstufung | Tudor Pickering | Hold → Buy |
2018-12-19 | Herabstufung | Credit Suisse | Outperform → Neutral |
2018-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
2018-11-16 | Hochstufung | Guggenheim | Neutral → Buy |
2018-11-01 | Hochstufung | ABN Amro | Sell → Buy |
2018-10-29 | Bestätigt | Cowen | Market Perform |
Alle ansehen
Core Laboratories Inc Aktie (CLB) Neueste Nachrichten
Jane Street Group LLC Buys 25,189 Shares of Core Laboratories Inc. (NYSE:CLB) - Defense World
Geode Capital Management LLC Purchases 7,721 Shares of Core Laboratories Inc. (NYSE:CLB) - Defense World
Barclays PLC Purchases 62,042 Shares of Core Laboratories Inc. (NYSE:CLB) - Defense World
Barclays PLC Acquires 62,042 Shares of Core Laboratories Inc. (NYSE:CLB) - MarketBeat
CORE LABORATORIES' THIRD QUARTER 2024 WEBCAST AT 7:30 A.M. CDT / 8:30 A.M. EDT ON OCTOBER 24 2024 - Quantisnow
Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket - Benzinga
Core Laboratories Inc. (NYSE:CLB) Shares Bought by Fmr LLC - Defense World
State Street Corp Has $36.60 Million Stock Position in Core Laboratories Inc. (NYSE:CLB) - Defense World
Core Laboratories Inc. (NYSE:CLB) Shares Purchased by State Street Corp - MarketBeat
Core Laboratories (NYSE:CLB) Shares Down 2.6%Time to Sell? - MarketBeat
Core Laboratories Inc. (NYSE:CLB) Short Interest Down 5.1% in November - Defense World
The Manufacturers Life Insurance Company Has $399,000 Stake in Core Laboratories Inc. (NYSE:CLB) - Defense World
Is Now the Right Time to Buy Core Laboratories After Its 14% YTD Rise? - MSN
Is Now the Right Time to Buy Core Laboratories After Its 12% YTD Rise? - Yahoo Finance
Charles Schwab Investment Management Inc. Has $9.81 Million Position in Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Disciplined Growth Investors Inc. MN Has $104.76 Million Stock Holdings in Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Charles Schwab Investment Management Inc. Reduces Stake in Core Laboratories Inc. (NYSE:CLB) - Defense World
Captrust Financial Advisors Invests $997,000 in Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Returns On Capital At Core Laboratories (NYSE:CLB) Paint A Concerning Picture - Simply Wall St
Core Laboratories (NYSE:CLB) Stock Price Down 4% – Time to Sell? - Defense World
Core Laboratories (NYSE:CLB) Trading Down 4%What's Next? - MarketBeat
Zacks Research Brokers Decrease Earnings Estimates for CLB - Defense World
Zacks Research Cuts Earnings Estimates for Core Laboratories - MarketBeat
Zacks Research Issues Pessimistic Estimate for CLB Earnings - Defense World
Is Core Laboratories Inc.'s (NYSE:CLB) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - Yahoo Finance
Core Laboratories (STU:HJ1) Dividend Payout Ratio : 0.04 (As of Sep. 2024) - GuruFocus.com
Core Laboratories Inc. (NYSE:CLB) Shares Sold by Thrivent Financial for Lutherans - Defense World
Core Laboratories (STU:HJ1) Altman Z-Score : 3.57 (As of Dec. 05, 2024) - GuruFocus.com
PEAK6 Investments LLC Has $384,000 Stake in Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Core Laboratories (LTS:0Q82) Price-to-Free-Cash-Flow : 27.55 (As of Dec. 01, 2024) - GuruFocus.com
CLB (Core Laboratories) 3-Year EPS without NRI Growth Rate : 166.10% (As of Sep. 2024) - GuruFocus.com
Fisher Asset Management LLC Has $18.35 Million Stock Holdings in Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Core Laboratories (FRA:HJ1) Cash Flow from Investing : €-4.8 Mil (TTM As of Sep. 2024) - GuruFocus.com
Core Laboratories (FRA:HJ1) Earnings Yield % : 2.56% (As of Nov. 27, 2024) - GuruFocus.com
Core Laboratories (FRA:HJ1) Future 3-5Y EPS without NRI Gro - GuruFocus.com
Core Laboratories (FRA:HJ1) Cash Flow from Operations : €50.6 Mil (TTM As of Sep. 2024) - GuruFocus.com
Core Laboratories (FRA:HJ1) Free Cash Flow per Share : €0.85 (TTM As of Sep. 2024) - GuruFocus.com
Core Laboratories (FRA:HJ1) 5-Year Yield-on-Cost % : 0.00 (As of Nov. 27, 2024) - GuruFocus.com
Core Laboratories (FRA:HJ1) EPS without NRI : €0.65 (TTM As of Sep. 2024) - GuruFocus.com
Core Laboratories (FRA:HJ1) EBITDA per Share : €1.42 (TTM As of Sep. 2024) - GuruFocus.com
Core Laboratories (FRA:HJ1) Operating Income : €48.9 Mil (TTM As of Sep. 2024) - GuruFocus.com
Core Laboratories (FRA:HJ1) Cyclically Adjusted PB Ratio : 6.41 (As of Nov. 26, 2024) - GuruFocus.com
Core Laboratories (FRA:HJ1) Total Inventories : €59.0 Mil (As of Sep. 2024) - GuruFocus.com
Eagle Asset Management Inc. Makes New $3.53 Million Investment in Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Oppenheimer & Co. Inc. Reduces Stock Position in Core Laboratories Inc. (NYSE:CLB) - Defense World
Why Is Core Laboratories (CLB) Up 11.5% Since Last Earnings Report? - Yahoo Finance
Core Laboratories (STU:HJ1) Profitability Rank : 7 (As of Sep. 2024) - GuruFocus.com
Principal Financial Group Inc. Has $4.12 Million Position in Core Laboratories Inc. (NYSE:CLB) - Defense World
Core Laboratories Inc (CLB) Stock Price Up 4.78% on Nov 21 - GuruFocus.com
GSA Capital Partners LLP Makes New Investment in Core Laboratories Inc. (NYSE:CLB) - Defense World
Core Laboratories (FRA:HJ1) Price-to-Operating-Cash-Flow : 17.50 (As of Nov. 20, 2024) - GuruFocus.com
Finanzdaten der Core Laboratories Inc-Aktie (CLB)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):